5OFA
Crystal structure of human MORC2 (residues 1-603) with spinal muscular atrophy mutation T424R
GO(遺伝子オントロジー)由来の情報
鎖名 | GO(遺伝子オントロジー)id | 名前空間 | 内容 |
A | 0008270 | molecular_function | zinc ion binding |
B | 0008270 | molecular_function | zinc ion binding |
PDBデータベースに由来する情報
site_id | AC1 |
残基数 | 4 |
詳細 | binding site for residue ZN B 701 |
鎖名 | 残基 |
B | CYS499 |
B | CYS502 |
B | CYS525 |
B | CYS536 |
site_id | AC2 |
残基数 | 22 |
詳細 | binding site for residue ANP B 702 |
鎖名 | 残基 |
B | VAL81 |
B | SER87 |
B | LYS89 |
B | GLY98 |
B | GLN99 |
B | TYR100 |
B | GLY101 |
B | ASN102 |
B | GLY103 |
B | LEU104 |
B | LYS105 |
B | THR197 |
B | LYS427 |
B | MG703 |
B | HOH805 |
B | HOH806 |
B | HOH814 |
B | GLU35 |
B | ASN39 |
B | ALA43 |
B | ASP68 |
B | MET73 |
site_id | AC3 |
残基数 | 3 |
詳細 | binding site for residue MG B 703 |
site_id | AC4 |
残基数 | 4 |
詳細 | binding site for residue ZN A 701 |
鎖名 | 残基 |
A | CYS499 |
A | CYS502 |
A | CYS525 |
A | CYS536 |
site_id | AC5 |
残基数 | 22 |
詳細 | binding site for residue ANP A 702 |
鎖名 | 残基 |
A | GLU35 |
A | ASN39 |
A | ALA43 |
A | ASP68 |
A | MET73 |
A | VAL81 |
A | SER87 |
A | LYS89 |
A | GLY98 |
A | GLN99 |
A | TYR100 |
A | GLY101 |
A | ASN102 |
A | GLY103 |
A | LEU104 |
A | LYS105 |
A | THR197 |
A | LYS427 |
A | MG703 |
A | HOH808 |
A | HOH810 |
A | HOH811 |
site_id | AC6 |
残基数 | 4 |
詳細 | binding site for residue MG A 703 |
鎖名 | 残基 |
A | ASN39 |
A | ANP702 |
A | HOH808 |
A | HOH810 |
SwissProt/UniProtに記載されている蛋白質分子機能情報
鎖名 | 残基 | 詳細 |
B | ALA490-LYS544 | |
A | ALA490-LYS544 | |
鎖名 | 残基 | 詳細 |
B | ASN39 | |
B | SER87 | |
B | GLN99 | |
B | LYS427 | |
A | ASN39 | |
A | SER87 | |
A | GLN99 | |
A | LYS427 | |
鎖名 | 残基 | 詳細 |
B | CYS499 | |
B | CYS502 | |
B | CYS525 | |
B | CYS536 | |
A | CYS499 | |
A | CYS502 | |
A | CYS525 | |
A | CYS536 | |